Panel Discussion: The Lack of Robust Surrogate Biomarkers for Aging

Time: 11:30 am
day: Day One


Join keynote speakers as they discuss the lack of robust biomarkers in the longevity field and methods to overcome this including:

  • Evaluating novel biomarkers that may correlate to registrable endpoints in longevity therapeutics
  • Assessing how to move novel biomarkers towards regulatory approval
  • Discussing the importance of developing defined biomarkers for aging and how we can use robust biomarkers to move the longevity field forward